Skip to main content
STI & HIV 2023 World Congress Main banner
Final Program


Icon Legend

  1. Home

  • Tuesday, Jul 25th
    10:00 – 10:15 CST
    O1.1 - Bacterial Vaginosis and Spontaneous Clearance of Urogenital Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora
    Location: Chicago 8
    Primary Presenter: Sarah E. Brown (she/her/hers) – University of Maryland School of Medicine
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    10:00 – 10:15 CST
    O3.1 - Evaluating the clinical features of reported breakthrough cases of congenital syphilis — United States, 2016–2020
    Location: Chicago 10
    Primary Presenter: Kevin P. O'Callaghan, MB BCh BAO (he/him/his) – Centers for Disease Control and Prevention
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    10:15 – 10:30 CST
    O3.2 - Rates of reported primary and secondary syphilis among men who have sex with men compared to men who have sex with women only and women who have sex with men in 37 US states, 2018
    Location: Chicago 10
    Primary Presenter: Jeremy A. Grey, PhD (he/him/his) – CDC
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    11:00 – 11:15 CST
    O3.5 - Temporal Trends in HIV Status by Race/Ethnicity Among Reported Primary and Secondary Syphilis Cases Among Gay, Bisexual, and Other Men who have sex with Men — United States, 2011–2020
    Location: Chicago 10
    Primary Presenter: Sarah Wondmeneh, MD, MPH – Centers for Disease Control and Prevention
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    14:30 – 14:45 CST
    O4.1 - Exploring current etiologies of urethritis: associations of urethral microorganisms and urethritis among men attending 6 STD clinics in the US, 2017-2018
    Location: Chicago 8
    Primary Presenter: Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    14:30 – 14:45 CST
    LB1.1 - Prevalence and epidemiology of Lymphogranuloma venereum in France, 2020-2022
    Location: Michigan A+B
    Primary Presenter: Cecile Bebear, MD PhD (she/her/hers) – Bordeaux University Hospital
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    14:45 – 15:00 CST
    O6.2 - Syphilis testing, incidence, and reinfection among gay and bisexual men with and without HIV in Australia over a decade spanning HIV PrEP implementation
    Location: Chicago 10
    Primary Presenter: Michael W. Traeger, PhD (he/him/his) – Burnet Institute
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    14:45 – 15:00 CST
    LB1.2 - Genetic diversity of Chlamydia trachomatis infection among patients presenting with genital lesions in Malawi
    Location: Michigan A+B
    Primary Presenter: Christopher M. Hennelly, n/a – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:00 – 15:15 CST
    O5.3 - Concordance between self-reported PrEP use using a diary app and intracellular tenofovir diphosphate in the Amsterdam PrEP demonstration project
    Location: Chicago 9
    Primary Presenter: Eline S. Wijstma (she/her/hers) – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
    Primary Presenter: Maarten Schim van der Loeff – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:15 – 15:30 CST
    O4.4 - Mycoplasma genitalium Surveillance Data from 2020-2022: Results from the Mycoplasma genitalium in the US (MyGeniUS) Project
    Location: Chicago 8
    Primary Presenter: Lisa E. Manhart, MPH, PhD – University of Washington
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:15 – 15:30 CST
    O5.4 - Age patterns of HSV-2 incidence and prevalence in two communities in Rakai, Uganda: a catalytic incidence model applied to population-based seroprevalence data
    Location: Chicago 9
    Primary Presenter: Lilith K. Whittles, PhD (she/her/hers) – Imperial College London
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:15 – 15:30 CST
    O6.4 - A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance
    Location: Chicago 10
    Primary Presenter: Tatum D. Mortimer, PhD (she/her/hers) – Harvard T.H. Chan School of Public Health
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:15 – 15:30 CST
    LB1.4 - Mpox resurgence in 2023 in Toronto, Canada – surveillance and vaccine approaches
    Location: Michigan A+B
    Primary Presenter: Sylvia Ota, MHSc (she/her/hers) – Toronto Public Health
    Co-Author: Rita Shahin, n/a – Toronto Public Health
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:30 – 15:45 CST
    LB1.5 - Modelling the impact of vaccination and sexual behavior adaptation on reported cases of mpox in Washington D.C.
    Location: Michigan A+B
    Primary Presenter: Patrick A. Clay, PhD (he/him/his) – Centers for Disease Control and Prevention
    Epidemiology & Monitoring
  • Tuesday, Jul 25th
    15:45 – 16:00 CST
    LB1.6 - Modeling potential mpox resurgence among gay, bisexual, and other men who have sex with men in Washington, DC.
    Location: Michigan A+B
    Primary Presenter: Emily D. Pollock, PhD (she/her/hers) – Centers for Disease Control & Prevention
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    10:00 – 10:15 CST
    O7.1 - Within-person differences of N. gonorrhoeae antimicrobial resistance patterns between anatomical locations
    Location: Chicago 8
    Primary Presenter: Maartje Visser, MSc (she/her/hers) – National Institute for Public Health and the Environment (RIVM)
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    10:00 – 10:15 CST
    O9.1 - The clinical and genomic diversity of Treponema pallidum among early syphilis patients enrolled in a global consortium for syphilis vaccine development
    Location: Chicago 10
    Primary Presenter: Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    10:15 – 10:30 CST
    O8.2 - Artificial intelligence-assisted diagnostic tool for early detection of sexually transmitted infections
    Location: Chicago 9
    Primary Presenter: Lei Zhang, PhD (he/him/his) – Central Clinical School, Monash University
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    10:30 – 10:45 CST
    O8.3 - Adapting an Artificial Intelligence Sexually Transmitted Infections Screening Tool for Monkeypox Detection: The HeHealth Experience
    Location: Chicago 9
    Primary Presenter: Yudara Kularathne, MD, FAMS – HeHealth.ai
    Co-Author: Rayner KJ Tan, PhD – University of North Carolina at Chapel Hill
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    10:45 – 11:00 CST
    O8.4 - Health Information Exchange Enables Enhanced STI Surveillance Using Electronic Health Record Data
    Location: Chicago 9
    Primary Presenter: Harry Reyes Nieva, MAS, MA, MPhil (he/him/his) – Columbia University
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    11:15 – 11:30 CST
    O7.6 - Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study
    Location: Chicago 8
    Primary Presenter: Yonatan H. Grad, MD, PhD – Harvard T.H. Chan School of Public Health
    Co-Author: Emily Reichert – Harvard T.H. Chan School of Public Health
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    13:38 – 13:42 CST
    YI5 - Effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening on post-delivery prevalence and vertical transmission in Gaborone, Botswana
    Location: Sheraton Ballroom
    Primary Presenter: Aamirah Mussa, MPH – University of Edinburgh / Botswana Harvard Partnership
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    13:48 – 13:57 CST
    YI7 - Predicting the Potential Impact of a Novel Chlamydia Vaccine in the United States
    Location: Sheraton Ballroom
    Primary Presenter: Monia Makhoul, Ph.D – Weill Cornell Medicine Qatar
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    14:30 – 14:45 CST
    LB2.1 - Evolving antimicrobial resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis
    Location: Michigan A+B
    Primary Presenter: Teck-Phui Chua – University of Melbourne
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    14:30 – 14:45 CST
    O10.1 - What is the true global burden of sexually transmitted infections? What is and is not included in the Global Burden of Disease estimates
    Location: Chicago 8
    Primary Presenter: Nicola Low, MD (she/her/hers) – University of Bern
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    14:45 – 15:00 CST
    O10.2 - STI epidemiology in the time of COVID-19 pandemic in European Union/European Economic Area (EU/EEA) countries– data artifact or real impact of the pandemic?
    Location: Chicago 8
    Primary Presenter: Otilia Mårdh, MD, MSc – European Centre for Diseases Prevention and Control (ECDC)
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    14:45 – 15:00 CST
    O11.2 - Global Surveillance for Antimicrobial Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2015-2022
    Location: Chicago 9
    Primary Presenter: Rebekah Frankson, MS, MPH – U.S. Centers for Disease Control and Prevention
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:00 – 15:15 CST
    O10.3 - Gini coefficients for measuring the disparity in the distribution of HIV and sexually transmitted infections in both heterosexual and homosexual populations in Australia
    Location: Chicago 8
    Primary Presenter: Lei Zhang, PhD (he/him/his) – Central Clinical School, Monash University
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:00 – 15:15 CST
    O11.3 - Should we use the 4CMenB (Bexsero®) meningitis vaccine to protect men who have sex with men (MSM) in England against gonorrhoea? A model-based analysis of impact and cost-effectiveness.
    Location: Chicago 9
    Primary Presenter: Dariya Nikitin, MSc, MRes – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:15 – 15:30 CST
    LB2.4 - Initial findings from increased gonorrhea culture surveillance in Massachusetts
    Location: Michigan A+B
    Primary Presenter: Heather R. Elder, PhD, MPH (she/her/hers) – Massachusetts Department of Public Health
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:30 – 15:45 CST
    LB2.5 - Detection of two ceftriaxone non-susceptible Neisseria gonorrhoeae isolates in an HIV pre-exposure prophylaxis program in Vietnam
    Location: Michigan A+B
    Primary Presenter: Paul Adamson, MD MPH (he/him/his) – Division of Infectious Diseases, UCLA School of Medicine
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:30 – 15:45 CST
    O10.5 - Sexual and reproductive health among migrant peoples in transit through Darién, Panama: results from a rapid epidemiological study
    Location: Chicago 8
    Primary Presenter: Jennifer Toller Erausquin, PhD, MPH (she/her/hers) – University of North Carolina at Greensboro & Center of Population Sciences for Health Equity, College of Nursing, Florida State University
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:30 – 15:45 CST
    O11.5 - Targeted metagenomic analysis shows distinct Neisseria gonorrhoeae strains at separate anatomical sites occur more commonly than mixed strain infections: implications for surveillance
    Location: Chicago 9
    Primary Presenter: Petra FG Wolffs, PhD (she/her/hers) – Maastricht University Medical Center+
    Co-Author: Brian MJW van der veer – Maastricht University Medical Center+
    Epidemiology & Monitoring
  • Wednesday, Jul 26th
    15:45 – 16:00 CST
    O11.6 - Effect of oropharyngeal colonization with Neisseria meningitidis on subsequent risk of gonorrhea
    Location: Chicago 9
    Primary Presenter: Abigail Norris Turner, PhD – Ohio State University
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:00 – 10:15 CST
    O13.1 - Mpox in Germany, 2022: a shift from event-linked travel-associated transmission to a large autochthonous outbreak
    Location: Michigan A/B
    Primary Presenter: Klaus Jansen, Dphil (he/him/his) – Robert Koch Institute
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:00 – 10:15 CST
    O14.1 - A Machine Learning Classifier to predict if Users will Return an Online Postal STI Test Kit using data captured during request processes
    Location: Superior A/B
    Primary Presenter: Efejiro E. Ashano, MSc. – Preventx
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:00 – 10:15 CST
    O15.1 - Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and fertility in women: final results of the Netherlands Chlamydia Cohort Study (NECCST)
    Location: Sheraton 1
    Primary Presenter: Zoïe W. Alexiou, MSc (she/her/hers) – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands. zoie.alexiou@rivm.nl
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:15 – 10:30 CST
    O15.2 - Oral inoculation of Chlamydia trachomatis (CT) can lead to viable rectal CT infection
    Location: Sheraton 1
    Primary Presenter: Christine M. Khosropour, MPH, PhD – University of Washington
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:15 – 10:30 CST
    O13.2 - Clinically inapparent mpox cases among visitors of three anonymous HIV/STI testing centers in Berlin, Germany, April–October, 2022
    Location: Michigan A/B
    Primary Presenter: Uwe Koppe, Dr. rer. nat. (he/him/his) – Robert Koch Institute
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:30 – 10:45 CST
    O13.3 - Case-Control Study of Risk Factors Associated with Mpox, San Francisco, CA, July–October, 2022
    Location: Michigan A/B
    Primary Presenter: Julia M. Janssen, MD – San Francisco Department of Public Health
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    10:45 – 11:00 CST
    O13.4 - MPOX AMONG MSM IN THE NETHERLANDS PRIOR TO MAY 2022, A RETROSPECTIVE STUDY
    Location: Michigan A/B
    Primary Presenter: Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    11:00 – 11:15 CST
    O14.5 - The impact of HIV/STI knowledge on HIV testing and sexual behaviors among American Indians in Southern California
    Location: Superior A/B
    Primary Presenter: Tommi Gaines – University of California, San Diego
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    11:00 – 11:15 CST
    O15.5 - Evaluating Chlamydia trachomatis and Neisseria Gonorrhoeae screening among asymptomatic pregnant women to prevent preterm birth and low birth weight in Gaborone, Botswana.
    Location: Sheraton 1
    Primary Presenter: Adriane Wynn, PhD (she/her/hers) – University of California, San Diego
    Epidemiology & Monitoring
  • Thursday, Jul 27th
    11:15 – 11:30 CST
    O15.6 - Chlamydia trachomatis IgG seropositivity: who becomes and remains positive?
    Location: Sheraton 1
    Primary Presenter: Zoïe W. Alexiou, MSc (she/her/hers) – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands. zoie.alexiou@rivm.nl
    Epidemiology & Monitoring